Date published: 2026-6-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Per1 Inhibitors

Per1 inhibitors are a class of chemical compounds that have garnered significant attention in the field of molecular biology and circadian rhythm research. These inhibitors specifically target the Period 1 (Per1) gene, which is a critical component of the circadian clock mechanism in most organisms, including humans. The circadian clock is a sophisticated biological timekeeping system that regulates various physiological processes, such as sleep-wake cycles, hormone secretion, and metabolism, to ensure that they follow a roughly 24-hour rhythm. Per1, along with other clock genes, plays a central role in the generation and maintenance of these circadian rhythms.

The Per1 gene codes for a protein known as PER1, which, in collaboration with other clock proteins, undergoes a complex cycle of synthesis and degradation to regulate circadian rhythms. Per1 inhibitors are designed to interfere with this cycle, typically by suppressing the expression or activity of PER1. By doing so, these inhibitors can disrupt the normal functioning of the circadian clock, leading to a range of effects on the organism's daily physiological and behavioral patterns. Researchers utilize Per1 inhibitors as valuable tools to manipulate and study circadian rhythms in experimental settings. Understanding the precise mechanisms by which Per1 inhibitors impact the circadian clock can provide insights into the broader field of chronobiology and may have implications in various domains, including sleep disorders, jet lag, and shift work adaptation, although these potential applications are beyond the scope of this description.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$26.00
$119.00
$213.00
27
(1)

Targets BCR-ABL kinase to inhibit cell proliferation in CML.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Inhibits RAF kinases and VEGF receptors in cancer signaling.

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$245.00
$1051.00
7
(1)

Acts as an androgen receptor antagonist in prostate cancer.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$251.00
$500.00
$547.00
16
(1)

Inhibits JAK1/2 kinases to reduce cytokine signaling in MPNs.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

Blocks EGFR kinase activity in non-small cell lung cancer.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Inhibits the proteasome, leading to cell death in myeloma.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$131.00
$651.00
7
(1)

Targets mTOR to suppress cell growth in various cancers.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Inhibits BTK kinase in B-cell malignancies, disrupting signaling.

Osimertinib

1421373-65-0sc-507355
5 mg
$86.00
(0)

Selectively inhibits EGFR in T790M-mutant lung cancer.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

Binds to BCL-2, promoting apoptosis in leukemia cells.